UNSPSC 51101614: Diloxanide furoate

This classification denotes an antiparasitic agent with the molecular formula C9H9Cl2NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 89134SCM7M, chemically known as 2,2-dichloro-4-hydroxy-n-methylacetanilide but generally known as diloxanide, which bears US NIH Compound Identifier 11367. European Medicines Agency schedules Diloxanide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07147MIG.

UNSPSC 51101614 Diloxanide furoate, a Commodity code, shows a mismatch between its nominal scope and the recent state and local procurement activity posted under it. The code nominally describes a specific pharmaceutical compound, but the recent opportunities tagged to this code reflect procurement of naloxone, safe drug deactivation systems, generic multi-source pharmaceuticals and OTC products, and therapeutic pharmacy services—none of which are diloxanide furoate. The issuing bodies include a county health department (Seminole County, Florida), a state health and human services agency (Texas HHS Commission), a city fire rescue division (City of Tampa), and a multistate cooperative purchasing alliance (Minnesota Multistate Cooperative Purchasing Alliance, MMCAP). This code shows no relevant recent activity aligned to its actual commodity name.

The geographic spread of activity spans Florida, Texas, Minnesota, and Oregon through the cooperative purchasing vehicle. Recent opportunities include Seminole County's competitive bid (IFB) for naloxone and drug deactivation systems due July 26, 2023 (posted June 30, 2026), the Texas HHS Commission's Request for Information on direct-to-manufacturer prescription programs due April 3, 2026, the City of Tampa's invitation to bid for medical and first aid supplies (estimated $700,000) due March 13, 2026 with SLBE set-asides and a 5 percent discount cap of $10,000, and MMCAP's RFP for generic pharmaceuticals and OTC products due March 26, 2026, serving multiple state and local government facilities. The code's tagging appears to be a taxonomy classification error; firms pursuing state and local pharmaceutical and medical supply contracts should verify accurate UNSPSC alignment before responding to opportunities in this family.